Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,187 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,187 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,187 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,187 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,187 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,187 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,187 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
20 Feb 2026
Sold on a plan
$536.16K 15,700 at 34.15
52.7%
Sold half or more
20 Feb 2026
Nathan Blecharczyk Chief Strategy Officer
Sold on a plan
$533.74K 4,260 at 125.29
8.0%
Planned (10b5-1)
20 Feb 2026
Peter Platzer Executive Chairman
Sold on a plan
$498.39K 58,428 at 8.53
3.3%
Planned (10b5-1)
20 Feb 2026
Sold on a plan
$475.36K 2,000 at 237.68
1.8%
Planned (10b5-1)
20 Feb 2026
Christopher Mutz Head of Rare Disease
Sold on a plan
$415.30K 5,323 at 78.02
5.9%
Planned (10b5-1)
20 Feb 2026
Kimberly K. Nelson EVP & CFO
Sold on a plan 3×
$369.53K 6,300 at 58.66
4.2%
Planned (10b5-1)
20 Feb 2026
Jack Bendheim President and CEO · indirect
Sold on a plan 2×
$361.97K 7,040 at 51.42
23.8%
Planned (10b5-1)
20 Feb 2026
Jeffrey Buckley See Remarks
Sold on a plan 5×
$361.57K 2,704 at 133.72
5.7%
Planned (10b5-1)
20 Feb 2026
Theresa Condor Chief Executive Officer
Sold on a plan
$355.80K 41,712 at 8.53
3.6%
Planned (10b5-1)
20 Feb 2026
Stefan J. Murry Chief Financial Officer
Sold on a plan
$299.92K 5,980 at 50.15
2.1%
Planned (10b5-1)
20 Feb 2026
Arora Ashish Chief Executive Officer
Sold on a plan
$277.41K 60,000 at 4.62
1.5%
Planned (10b5-1)
20 Feb 2026
Timothy Holme Chief Technology Officer
Sold on a plan
$237.72K 34,120 at 6.97
3.0%
Planned (10b5-1)
20 Feb 2026
Olivier Blachier SVP, Chief Strategy Officer
Sold on a plan 3×
$218.80K 1,664 at 131.49
5.3%
Planned (10b5-1)
20 Feb 2026
Pamela Esposito Director
Sold on a plan 2×
$218.27K 2,500 at 87.31
100%
Sold half or more
20 Feb 2026
Jayme Mendal CEO and President
Sold on a plan 2×
$215.18K 14,360 at 14.98
2.6%
Planned (10b5-1)
20 Feb 2026
Joseph Colella SVP and General Counsel
Sold on a plan 2×
$207.75K 1,580 at 131.49
3.3%
Planned (10b5-1)
20 Feb 2026
Ernie J Garateix Chief Executive Officer
Sold on a plan 2×
$201.00K 8,334 at 24.12
0.7%
Planned (10b5-1)
20 Feb 2026
Robert Buckley Chief Financial Officer
Sold on a plan 3×
$200.47K 1,423 at 140.88
1.5%
Planned (10b5-1)
20 Feb 2026
Scott Darling Chief Legal Officer
Sold on a plan
$193.39K 6,478 at 29.85
7.0%
Planned (10b5-1)
20 Feb 2026
Kelli Keough EVP, Gbul, Sips
Sold on a plan
$184.12K 9,755 at 18.87
3.2%
Planned (10b5-1)
20 Feb 2026
Robert Thomas Dechant Chief Executive Officer
Sold on a plan
$176.40K 6,000 at 29.40
2.1%
Planned (10b5-1)
20 Feb 2026
Jennifer Michaelson Chief Scientific Officer
Sold on a plan 2×
$165.37K 11,742 at 14.08
6.1%
Planned (10b5-1)
20 Feb 2026
Perez Celia Pelez Chief Operating Officer
Sold on a plan
$163.21K 19,134 at 8.53
6.7%
Planned (10b5-1)
20 Feb 2026
Scott M Davies Chief Legal Officer
Sold on a plan
$155.22K 1,336 at 116.18
7.6%
Planned (10b5-1)
20 Feb 2026
Krista Davis SVP, Chief HR Officer
Sold on a plan
$134.92K 1,730 at 77.99
3.4%
Planned (10b5-1)
20 Feb 2026
Adam Eltoukhy See Remarks
Sold on a plan 2×
$125.61K 4,688 at 26.79
1.9%
Planned (10b5-1)
20 Feb 2026
Johann Gabriel Oehme Chief Technology Officer
Sold on a plan
$108.82K 12,757 at 8.53
5.5%
Planned (10b5-1)
20 Feb 2026
Barry J. Simon Director
Sold on a plan
$92.50K 10,000 at 9.25
0.3%
Planned (10b5-1)
20 Feb 2026
Tyrone Graham EVP, Chief HR Officer
Sold on a plan
$91.19K 2,285 at 39.91
14.5%
Planned (10b5-1)
20 Feb 2026
John Downing EVP, World-Wide Sales
Sold on a plan
$90.00K 3,000 at 30.00
2.3%
Planned (10b5-1)
20 Feb 2026
Brandon John Moore President, COO, and Secretary
Sold on a plan
$66.11K 1,376 at 48.05
0.5%
Planned (10b5-1)
20 Feb 2026
Bruce K Posey Chief Legal Officer
Sold on a plan 3×
$49.95K 481 at 103.85
0.7%
Planned (10b5-1)
20 Feb 2026
Brian McGee EVP, CFO and COO
Sold on a plan
$47.14K 59,509 at 0.79
8.0%
Planned (10b5-1)
20 Feb 2026
Christopher Bohrson Sr VP & Chief Customer Officer
Sold on a plan
$30.23K 1,000 at 30.23
0.6%
Planned (10b5-1)
20 Feb 2026
Nadia Waheed Chief Medical Officer
Sold on a plan
$27.17K 3,510 at 7.74
1.1%
Planned (10b5-1)
20 Feb 2026
Randall K Fields Chief Executive Officer · indirect
Sold on a plan
$26.47K 3,000 at 8.82
2.7%
Planned (10b5-1)
20 Feb 2026
Austin M Woffinden EVP, Corp. Ops & Strategy
Sold on a plan
$20.56K 263 at 78.16
1.3%
Planned (10b5-1)
20 Feb 2026
Mike Zoi 10% owner · indirect
Sold on a plan
$16.32K 4,959 at 3.29
0.3%
Planned (10b5-1)
20 Feb 2026
Sold on a plan
$13.73K 67 at 204.92
0.5%
Planned (10b5-1)
20 Feb 2026
Alison Sasser SVP - Chief Accounting Officer
Sold on a plan
$12.35K 158 at 78.16
1.8%
Planned (10b5-1)
20 Feb 2026
Scott Darling Chief Legal Officer · indirect
Sold on a plan
$11.80K 390 at 30.25
1.2%
Planned (10b5-1)
19 Feb 2026
Frank Torti President and Vant Chair
Sold on a plan
$38.39M 1,400,000 at 27.42
9.2%
Planned (10b5-1)
19 Feb 2026
Amit Sachdev EVP Chief Patient & Ext Af Off
Sold on a plan 8×
$27.48M 58,613 at 468.83
49.9%
Planned (10b5-1)
19 Feb 2026
Bought on a plan 2×
$24.37M 345,000 at 70.65
0.6%
Bought on a plan
19 Feb 2026
James Dimon Chairman & CEO · indirect
Sold on a plan 6×
$21.35M 69,512 at 307.19
1.6%
Planned (10b5-1)
19 Feb 2026
Troy L Rohrbaugh Co-CEO CIB
Sold on a plan
$15.36M 50,000 at 307.11
31.0%
Planned (10b5-1)
19 Feb 2026
Eric P Lefkofsky CEO and Chairman · indirect
Sold on a plan 6×
$9.79M 166,250 at 58.87
1.8%
Planned (10b5-1)
19 Feb 2026
Michelle Zatlyn President and Board Co-Chair · indirect
Sold on a plan 10×
$6.57M 35,080 at 187.39
50.4%
Sold half or more
19 Feb 2026
Paul A Mahon EVP & General Counsel
Sold on a plan 8×
$3.95M 8,300 at 476.34
18.4%
Planned (10b5-1)
19 Feb 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$3.02M 632,874 at 4.77
9.7%
Planned (10b5-1)
Showing 16,601–16,650 of 23,187. ← Newer Page 333 of 464 Older →